Owen CG, Jarrar Z, Wormald R, Cook DG, Fletcher AE, Rudnicka AR. The estimated prevalence and incidence of late stage age related macular degeneration in the UK. Br J Ophthalmol. 2012;96(5):752–6.

Article  PubMed  Google Scholar 

Wong WL, Su X, Li X, Cheung CM, Klein R, Cheng CY, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014;2(2):e106–16.

Article  PubMed  Google Scholar 

Hykin P, Chakravarthy U, Lotery A, McKibbin M, Napier J, Sivaprasad S. A retrospective study of the real-life utilization and effectiveness of ranibizumab therapy for neovascular age-related macular degeneration in the UK. Clin Ophthalmol. 2016;10:87–96.

CAS  PubMed  PubMed Central  Google Scholar 

Fritsche LG, Igl W, Bailey JN, Grassmann F, Sengupta S, Bragg-Gresham JL, et al. A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants. Nat Genet. 2015.

Merle BM, Silver RE, Rosner B, Seddon JM. Adherence to a mediterranean diet, genetic susceptibility, and progression to advanced macular degeneration: a prospective cohort study. Am J Clin Nutr. 2015;102(5):1196–1206.

Article  CAS  PubMed  PubMed Central  Google Scholar 

de Koning-Backus APM, Kiefte-de Jong JC, van Rooij JGJ, Amd-Life T, Uitterlinden AG, Voortman TG, et al. Lifestyle intervention randomized controlled trial for age-related macular degeneration (AMD-Life): study design. Nutrients. 2023;15(3):602.

Hampel H, Hardy J, Blennow K, Chen C, Perry G, Kim SH, et al. The Amyloid-β Pathway in Alzheimer’s Disease. Mol Psychiatry. 2021;26(10):5481–503.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lynn SA, Keeling E, Munday R, Gabha G, Griffiths H, Lotery AJ, et al. The complexities underlying age-related macular degeneration: could amyloid beta play an important role? Neural Regen Res. 2017;12(4):538–48.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Anderson DH, Talaga KC, Rivest AJ, Barron E, Hageman GS, Johnson LV. Characterization of beta amyloid assemblies in drusen: the deposits associated with aging and age-related macular degeneration. Exp Eye Res. 2004;78(2):243–56.

Article  CAS  PubMed  Google Scholar 

Johnson LV, Leitner WP, Rivest AJ, Staples MK, Radeke MJ, Anderson DH. The Alzheimer’s A beta -peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration. Proc Natl Acad Sci U S A. 2002;99(18):11830–5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Luibl V, Isas JM, Kayed R, Glabe CG, Langen R, Chen J. Drusen deposits associated with aging and age-related macular degeneration contain nonfibrillar amyloid oligomers. J Clin Invest. 2006;116(2):378–85.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Isas JM, Luibl V, Johnson LV, Kayed R, Wetzel R, Glabe CG, et al. Soluble and mature amyloid fibrils in drusen deposits. Invest Ophthalmol Vis Sci. 2010;51(3):1304–10.

Article  PubMed  PubMed Central  Google Scholar 

Dentchev T, Milam AH, Lee VM, Trojanowski JQ, Dunaief JL. Amyloid-beta is found in drusen from some age-related macular degeneration retinas, but not in drusen from normal retinas. Mol Vis. 2003;9:184–90.

CAS  PubMed  Google Scholar 

Guymer R, Cipriani T, Rittenhouse KD, Lim L, Robman LD, Li W, et al. Plasma levels of amyloid beta and other proinflammatory mediators in patients with age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2015;253(8):1347–54.

Article  CAS  PubMed  Google Scholar 

Zhu J, Su T, Wang M, Li M, Liu L, Wang F. Highly Expressed Amyloid Beta-42 Of Aqueous Humor In Patients With Neovascular Macular Degeneration. Semin Ophthalmol. 2021;36(1–2):9–13.

Article  PubMed  Google Scholar 

Koronyo Y, Rentsendorj A, Mirzaei N, Regis GC, Sheyn J, Shi H, et al. Retinal pathological features and proteome signatures of Alzheimer’s disease. Acta Neuropathol. 2023;145(4):409–38.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee S, Jiang K, McIlmoyle B, To E, Xu QA, Hirsch-Reinshagen V, et al. Amyloid Beta Immunoreactivity in the Retinal Ganglion Cell Layer of the Alzheimer’s Eye. Front Neurosci. 2020;14:758.

Article  PubMed  PubMed Central  Google Scholar 

Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, et al. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer’s disease mutations: potential factors in amyloid plaque formation. J Neurosci. 2006;26(40):10129–40.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Parthasarathy R, Chow KM, Derafshi Z, Fautsch MP, Hetling JR, Rodgers DW, et al. Reduction of amyloid-beta levels in mouse eye tissues by intra-vitreally delivered neprilysin. Exp Eye Res. 2015;138:134–44.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lynn SA, Johnston DA, Scott JA, Munday R, Desai RS, Keeling E, et al. Oligomeric Aβ(1–42) Induces an AMD-Like phenotype and accumulates in lysosomes to impair rpe function. Cells. 2021;10(2):413.

Truett GE, Heeger P, Mynatt RL, Truett AA, Walker JA, Warman ML. Preparation of PCR-quality mouse genomic DNA with hot sodium hydroxide and tris (HotSHOT). Biotechniques. 2000;29(1):52, 4.

Sanchez-Bretano A, Keeling E, Scott JA, Lynn SA, Soundara-Pandi SP, Macdonald SL, et al. Human equivalent doses of L-DOPA rescues retinal morphology and visual function in a murine model of albinism. Sci Rep. 2023;13(1):17173.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Au - Dietrich M, Au - Hecker C, Au - Hilla A, Au - Cruz-Herranz A, Au - Hartung H-P, Au - Fischer D, et al. Using Optical Coherence Tomography and Optokinetic Response As Structural and Functional Visual System Readouts in Mice and Rats. JoVE. 2019(143):e58571.

Xiao J, Adil MY, Chang K, Yu Z, Yang L, Utheim TP, et al. Visual Contrast Sensitivity Correlates to the Retinal Degeneration in Rhodopsin Knockout Mice. Invest Ophthalmol Vis Sci. 2019;60(13):4196–204.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee H, Scott J, Griffiths H, Self JE, Lotery A. Oral levodopa rescues retinal morphology and visual function in a murine model of human albinism. Pigment Cell Melanoma Res. 2019;32(5):657–71.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9(7):676–82.

Article  CAS  PubMed  Google Scholar 

Mezu-Ndubuisi OJ. In Vivo Angiography Quantifies Oxygen-Induced Retinopathy Vascular Recovery. Optom Vis Sci. 2016;93(10):1268–79.

Article  PubMed  PubMed Central  Google Scholar 

Chang B. Mouse models for studies of retinal degeneration and diseases. Methods Mol Biol. 2013;935:27–39.

Article  CAS  PubMed  Google Scholar 

O’Leary TP, Brown RE. Visuo-spatial learning and memory impairments in the 5xFAD mouse model of Alzheimer’s disease: Effects of age, sex, albinism, and motor impairments. Genes Brain Behav. 2022;21(4): e12794.

Article  PubMed  PubMed Central  Google Scholar 

Sevigny J, Chiao P, Bussière T, Weinreb PH, Williams L, Maier M, et al. The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease. Nature. 2016;537(7618):50–6.

Article  CAS  PubMed  Google Scholar 

van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, et al. Lecanemab in Early Alzheimer’s Disease. N Engl J Med. 2023;388(1):9–21.

Article  PubMed  Google Scholar 

Sims JR, Zimmer JA, Evans CD, Lu M, Ardayfio P, Sparks J, et al. Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial. JAMA. 2023;330(6):512–27.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Boche D, Nicoll JAR. Invited Review - Understanding cause and effect in Alzheimer’s pathophysiology: Implications for clinical trials. Neuropathol Appl Neurobiol. 2020;46(7):623–40.

Article  CAS  PubMed